Evidence map›Paper›PMID 36306122›Full record

ArticleTranslational vision science & technology2022

Attitudes Toward Glaucoma Genetic Risk Assessment in Unaffected Individuals.

Georgina L Hollitt, Owen M Siggs, Bronwyn Ridge, Miriam C Keane, David A Mackey, Stuart MacGregor, Alex W Hewitt, Jamie E Craig, Emmanuelle Souzeau

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Uptake of Polygenic Risk Testing for Glaucoma in Unaffected Individuals.Translational vision science & technology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Georgina L HollittDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.
Owen M SiggsDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.
Bronwyn RidgeDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.
Miriam C KeaneDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.
David A MackeyMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Stuart MacGregorQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Alex W HewittMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Jamie E CraigDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.
Emmanuelle SouzeauDepartment of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia.
Flinders Medical Centre · AUUniversity of Tasmania · AUFlinders University · AUQIMR Berghofer Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Integrating polygenic risk scores (PRS) into healthcare has the potential to stratify an individual's risk of glaucoma across a broad population. Glaucoma is the most common cause of irreversible blindness worldwide, therefore effective screening for glaucoma endorsed by the population is highly important. This study assessed the attitude of unaffected individuals toward PRS testing for glaucoma, and sought to identify factors associated with interest in testing. Methods: We surveyed 418 unaffected individuals including 193 with a first-degree relative with glaucoma, 117 who had a recent eye examination, and 108 general members of the community. Results: Overall, 71.3% of the individuals indicated an interest in taking a polygenic risk test for glaucoma. Interest was more likely in those who believed glaucoma to be a severe medical condition (odds ratio [OR] = 14.58, 95% confidence interval [CI] = 1.15-185.50, P = 0.039), those concerned about developing glaucoma (OR = 4.37, 95% CI = 2.32-8.25, P < 0.001), those with an intention to take appropriate measures regarding eye health (OR = 2.39, 95% CI = 1.16-4.95, P = 0.019), and those preferring to know if considered to be at-risk or not (OR = 4.52, 95% CI = 2.32-8.83, P < 0.001). Conclusions: Our results show strong interest in genetic risk assessment for glaucoma among unaffected individuals in Australia. Translational Relevance: These findings represent a valuable assessment of interest in glaucoma polygenic risk testing among potential target populations, which will be integral to the implementation and uptake of novel PRS-based tests into clinical practice.

Indexed as

GlaucomaDiagnostic Techniques, OphthalmologicalHumansMultifactorial InheritanceRisk AssessmentRisk Factors

Identifiers

PMID36306122
PMCPMC9624267
OpenAlexW4307712160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.